Retagliptin
Product Specifications
UNSPSC Description
Retagliptin (SP2086) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. Retagliptin can be used for type 2 diabetes mellitus (T2DM) research[1].
Target Antigen
Dipeptidyl Peptidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/retagliptin.html
Purity
99.70
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C2CN(C(C[C@H](N)CC3=CC(F)=C(F)C=C3F)=O)CCN2C(C(F)(F)F)=N1)OC
Molecular Weight
464.36
References & Citations
[1]Avivit Cahn, et al. An update on DPP-4 inhibitors in the management of type 2 diabetes. Expert Opin Emerg Drugs. 2016 Dec;21(4):409-419.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-112668A/Retagliptin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-112668A/Retagliptin-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
CAS Number
1174122-54-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6363834-01 0.2 mL
WWC1, NT (WWC1, KIAA0869, Protein KIBRA, HBeAg-binding protein 3, Kidney and brain protein, WW domain-containing protein 1) (Azide free) (HRP)
Ask
View Details 
MBS6363834-02 5x 0.2 mL
WWC1, NT (WWC1, KIAA0869, Protein KIBRA, HBeAg-binding protein 3, Kidney and brain protein, WW domain-containing protein 1) (Azide free) (HRP)
Ask
View Details